The acquisition of Epolin Chemicals LLC, with its global leadership in near-infrared absorbing dyes and thermoplastic compounds, significantly expands Chroma Color Corporation’s product offerings in targeted growth markets. Epolin serves customers developing groundbreaking products in sensors, security inks, light filters, touch-screens, night vision products, and eyewear. Epolin will operate as an independent subsidiary of Chroma Color and continue to maintain and invest in its strong customer and supplier relationships.
Fralock, a leading engineering and manufacturing provider of specialty material solutions for technically challenging and mission critical applications, announced today that it has completed the acquisition of Career Technologies USA. Fralock is a portfolio company of Arsenal Capital Partners, a specialized private equity firm with strong expertise in the specialty materials industry.
Meridian Adhesives Group (Meridian) announced today the acquisition of the adhesives division of John P. Kummer GmbH, AG and Ltd (JPK). JPK is a leading European distributor of specialty products for the electronic and medical markets. The acquisition is expected to close on April 30, 2020.
Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
Chroma Color Corporation continues to grow its manufacturing footprint along with its portfolio of colorant and additive technologies with its recent acquisition of Plastics Color Corporation, including its two facilities in Asheboro, North Carolina and Calumet City, Illinois. Terms of the transaction were not disclosed.
Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.